Daylight Solutions: Repligen Beefs Up Process Analytics Portfolio With DRS Daylight Solutions Pact

Repligen Corporation (NASDAQ: RGEN) entered into a strategic partnership and exclusive license agreement with DRS Daylight Solutions to expand the use of mid-infrared (mid-IR) technology in the bioprocessing market. Through this agreement, Repligen will assume responsibility for the commercialization of Culpeo and the development of future products ...Full story available on Benzinga.com